Dynamic contrast-enhanced MRI serves as a predictor of HIFU treatment outcome for uterine fibroids with hyperintensity in T2-weighted images

Zhao,Wen‑Peng; Chen,Jin‑Yun; Chen,Wen‑Zhi

doi:10.3892/etm.2015.2879

Dynamic contrast-enhanced MRI serves as a predictor of HIFU treatment outcome for uterine fibroids with hyperintensity in T2-weighted images

Authors:
- Wen‑Peng Zhao
- Jin‑Yun Chen
- Wen‑Zhi Chen
View Affiliations

Affiliations: State Key Laboratory of Ultrasound Engineering in Medicine Co‑founded by Chongqing and the Ministry of Science and Technology, Chongqing Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: November 18, 2015 https://doi.org/10.3892/etm.2015.2879
Pages: 328-334

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the efficacy of dynamic contrast‑enhanced magnetic resonance imaging (MRI) in predicting the outcome of using ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of uterine fibroids with T2 hyperintensity under MRI. A total of 131 uterine fibroids from 131 patients that appeared hyperintense under T2‑weighted MRI were analyzed. The uterine fibroids were subjectively categorized into slight, irregular or regular enhancement groups, according to pretreatment dynamic contrast‑enhanced MRI in the arterial phase within 60 sec after the injection of gadolinium. The non‑perfused volume (NPV), which is indicative of successful ablation, was represented as the non‑perfused area inside the uterine fibroids on enhanced MRI scans following treatment. Additionally, the treatment duration, treatment efficiency, sonication duration, energy efficiency ratio and any adverse events were recorded. The results indicated that the average NPV ratio for all the treated fibroids was 68.5%, while the average NPV ratios for fibroids with slight, irregular or regular enhancement were 84.7, 70.6 and 57.1%, respectively. Fibroids with regular enhancement were associated with the lowest NPV ratio and the lowest treatment efficiency, but exhibited the highest energy effect ratio and an elevated risk of severe adverse effects. The results of the present study indicate that hyperintense uterine fibroids with slight and irregular enhancement in the arterial phase of dynamic contrast‑enhanced MRI are suitable for USgHIFU treatment. By contrast, uterine fibroids with regular enhancement were associated with the lowest treatment efficacy and safety.

View Figures

View References

1	Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynyen K, Mcdannold N, Inbar Y, Itzchak Y, Rabinovici J, et al: MRI guidance of focused ultrasound therapy of uterine fibroids: Early results. AJR Am J Roentgenol. 183:1713–1719. 2004. View Article : Google Scholar : PubMed/NCBI
2	Stewart EA, Gostout B, Rabinovici J, Kim HS, Regan L and Tempany CM: Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 110:279–287. 2007. View Article : Google Scholar : PubMed/NCBI
3	Edozien LC: Costing magnetic resonance-guided focused ultrasound surgery, a new treatment for symptomatic fibroids. BJOG. 115:13212008. View Article : Google Scholar : PubMed/NCBI
4	Stewart EA, Rabinovici J, Tempany CM, Inbar Y, Regan L, Gostout B, Hesley G, Kim HS, Hengst S and Gedroyc WM: Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 85:22–29. 2006. View Article : Google Scholar : PubMed/NCBI
5	Fennessy FM, Tempany CM, McDannold NJ, So MJ, Hesley G, Gostout B, Kim HS, Holland GA, Sarti DA, Hynynen K, et al: Uterine leiomyomas: MR imaging-guided focused ultrasound surgery - results of different treatment protocols. Radiology. 243:885–893. 2007. View Article : Google Scholar : PubMed/NCBI
6	LeBlang SD, Hoctor K and Steinberg FL: Leiomyoma shrinkage after MRI-guided focused ultrasound treatment: Report of 80 patients. AJR Am J Roentgenol. 194:274–280. 2010. View Article : Google Scholar : PubMed/NCBI
7	Funaki K, Fukunishi H, Funaki T, Sawada K, Kaji Y and Maruo T: Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: Relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol. 196:184.e1–e6. 2007. View Article : Google Scholar
8	Lénárd ZM, McDannold NJ, Fennessy FM, Stewart EA, Jolesz FA, Hynynen K and Tempany CM: Uterine leiomyomas: MR imaging-guided focused ultrasound surgery - imaging predictors of success. Radiology. 249:187–194. 2008. View Article : Google Scholar : PubMed/NCBI
9	Funaki K, Fukunishi H and Sawada K: Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol. 34:584–589. 2009. View Article : Google Scholar : PubMed/NCBI
10	Gorny KR, Woodrum DA, Brown DL, Henrichsen TL, Weaver AL, Amrami KK, Hangiandreou NJ, Edmonson HA, Bouwsma EV, Stewart EA, et al: Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients. J Vasc Interv Radiol. 22:857–864. 2011. View Article : Google Scholar : PubMed/NCBI
11	Yoon SW, Lee C, Kim KA and Kim SH: Contrast-enhanced dynamic MR imaging of uterine fibroids as a potential predictor of patient eligibility for MR guided focused ultrasound (MRgFUS) treatment for symptomatic uterine fibroids. Obstet Gynecol Int. 2010:8342752010.PubMed/NCBI
12	Yamashita Y, Torashima M, Takahashi M, Tanaka N, Katabuchi H, Miyazaki K, Ito M and Okamura H: Hyperintense uterine leiomyoma at T2-weighted MR imaging: Differentiation with dynamic enhanced MR imaging and clinical implications. Radiology. 189:721–725. 1993. View Article : Google Scholar : PubMed/NCBI
13	Thomassin-Naggara I, Daraï E, Nassar-Slaba J, Cortez A, Marsault C and Bazot M: Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma. J Comput Assist Tomogr. 31:236–242. 2007. View Article : Google Scholar : PubMed/NCBI
14	McCaffery M: Using the 0-to-10 pain rating scale. Am J Nurs. 101:81–82. 2001. View Article : Google Scholar : PubMed/NCBI
15	Farrar JT, Pritchett YL, Robinson M, Prakash A and Chappell A: The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: Analyses of data from clinical trials of duloxetine in pain disorders. J Pain. 11:109–118. 2010. View Article : Google Scholar : PubMed/NCBI
16	Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD 3rd, Dupuy DE, Gervais DA, Gillams AR, Kane RA, Lee FT Jr, et al: Society of Interventional Radiology Technology Assessment Committee and the International Working Group on Image-guided Tumor Ablation: Image-guided tumor ablation: Standardization of terminology and reporting criteria. J Vasc Interv Radiol. 20(Suppl): S377–S390. 2009. View Article : Google Scholar : PubMed/NCBI
17	Oguchi O, Mori A, Kobayashi Y, Horiuchi A, Nikaido T and Fujii S: Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: correlation between T2-weighted images and effect of GnRH analogue. J Obstet Gynaecol (Tokyo 1995). 21:107–117. 1995. View Article : Google Scholar : PubMed/NCBI
18	Murase E, Siegelman ES, Outwater EK, Perez-Jaffe LA and Tureck RW: Uterine leiomyomas: Histopathologic features, MR imaging findings, differential diagnosis, and treatment. Radiographics. 19:1179–1197. 1999. View Article : Google Scholar : PubMed/NCBI
19	Shimada K, Ohashi I, Kasahara I, Watanabe H, Ohta S, Miyasaka N, Itoh E and Shibuya H: Differentiation between completely hyalinized uterine leiomyomas and ordinary leiomyomas: three-phase dynamic magnetic resonance imaging (MRI) vs. diffusion-weighted MRI with very small b-factors. J Magn Reson Imaging. 20:97–104. 2004. View Article : Google Scholar : PubMed/NCBI
20	Shimada K, Ohashi I, Kasahara I, Miyasaka N and Shibuya H: Triple-phase dynamic MRI of intratumoral vessel density and hyalinization grade in uterine leiomyomas. AJR Am J Roentgenol. 182:1043–1050. 2004. View Article : Google Scholar : PubMed/NCBI
21	Choyke PL, Dwyer AJ and Knopp MV: Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 17:509–520. 2003. View Article : Google Scholar : PubMed/NCBI
22	Yu T and Luo J: Adverse events of extracorporeal ultrasound-guided high intensity focused ultrasound therapy. PLoS One. 6:e261102011. View Article : Google Scholar : PubMed/NCBI
23	Yang WW, Zhu BR, Li J, Xia WX, Liu Y, Gai LH, Zhou JM and Sun JF: Analysis of complications of high intensity focused ultrasound in treatment of uterine leiomyoma. Zhong Hua Fu Chan Ke Za Zhi. 45:913–916. 2010.(In Chinese).